4441 studies found for:    "stem cells"
Show Display Options
Rank Status Study
1 Unknown  Stem Cell Educator Therapy in Alopecia Areata
Condition: Alopecia Areata
Intervention: Device: Stem Cell Educator
2 Recruiting Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
Conditions: Hematopoietic Stem Cell Transplantation;   Mesenchymal Stem Cells;   Umbilical Cord Blood;   Graft Failure;   Hematological Diseases
Interventions: Biological: Mesenchymal stem cells;   Biological: Mesenchymal stem cells and cord blood
3 Unknown  Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Stem cell therapy- SPD artery;   Other: Stem cell therapy- splenic artery;   Other: Stem cell therapy-intravenous;   Other: Normal saline placebo -sham procedure
4 Unknown  Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Mesenchymal Stem Cells;   Umbilical Cord
Intervention: Biological: umbilical cord mesenchymal stem cells
5 Unknown  Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis
Conditions: Ulcerative Colitis;   Mesenchymal Stem Cells;   Umbilical Cord
Intervention: Biological: Umbilical Cord Mesenchymal Stem Cells
6 Unknown  Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients
Conditions: Liver Cirrhosis;   Radiology;   Mesenchymal Stem Cells;   Umbilical Cord
Interventions: Biological: umbilical cord Mesenchymal Stem Cells;   Drug: Conserved therapy
7 Unknown  Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot
Conditions: Diabetic Foot;   Critical Limb Ischemia;   Mesenchymal Stem Cells;   Umbilical Cord
Interventions: Biological: umbilical cord mesenchymal stem cells;   Drug: Standard Therapy
8 Not yet recruiting Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting
Condition: Nonunion Fracture
Interventions: Biological: Mesenchymal Stem Cells;   Other: Culture medium without MSC.
9 Recruiting Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant
Conditions: Stem Cell Transplantation, Hematopoietic;   Mesenchymal Stem Cells;   Poor Graft Function;   Hematological Diseases
Intervention: Biological: Mesenchymal stem cells
10 Active, not recruiting Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Conditions: Breast Cancer;   Bone Metastases
Interventions: Drug: 153 Sm-EDTMP;   Behavioral: Questionnaire;   Procedure: Stem Cell Transplant
11 Completed Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Secondary AML;   Myelodysplastic Syndrome (MDS);   Secondary MDS;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia (JMML);   Paroxysmal Nocturnal Hemoglobinuria (PNH);   Lymphoma, Non-Hodgkin;   Hodgkin Disease
Interventions: Procedure: Stem Cell Transplantation;   Device: Miltenyi Biotec CliniMACS;   Drug: Systemic chemotherapy and antibodies
12 Terminated
Has Results
Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation
Condition: Acute Myeloid Leukemia (AML)
Interventions: Drug: G-CSF;   Drug: Leukapheresis;   Drug: Busulfan;   Procedure: Stem cell reinfusion
13 Withdrawn RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Procedure: hematopoietic stem cell mobilization;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Other: laboratory biomarker analysis
14 Recruiting Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy
Condition: Type 1 Diabetes
Intervention: Device: Stem Cell Educator
15 Completed CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction
Conditions: Recent Myocardial Infarction;   Ventricular Dysfunction
Intervention: Biological: Autologous stem cell infusion
16 Completed Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
Conditions: Allogeneic Stem Cell Transplant;   Leukemia;   Non-Hodgkins;   Lymphoblastic Lymphoma;   Myelodysplastic Syndrome;   Paroxysmal Nocturnal Hemoglobinuria (PNH)
Intervention: Drug: cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant
17 Completed Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury
Condition: Spinal Cord Injury
Intervention: Procedure: Stem Cell Transplantation
18 Recruiting Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures
Condition: Tibial Fracture
Interventions: Biological: Mesenchymal stem cell injection;   Biological: Placebo
19 Completed Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemias;   Acute Myelocytic Leukemia;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndrome;   Hemoglobinuria, Paroxysmal;   Non-Hodgkin Lymphoma
Interventions: Procedure: Allogeneic Stem Cell Transplantation;   Drug: Chemotherapy and antibodies
20 Completed Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
Conditions: Leukemia;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndrome;   Paroxysmal Nocturnal Hemoglobinuria;   Hodgkin's Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Drug: Systematic chemotherapy and antibodies;   Procedure: Allogeneic stem cell transplantation;   Device: Miltenyi CliniMACS

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years